PHYSIOLOGICAL DISPOSITION OF HMG-COA-REDUCTASE INHIBITORS

被引：74

作者：

DUGGAN, DE ^{[1
]}

VICKERS, S ^{[1
]}

机构：

[1] MERCK SHARP & DOHME LTD,W POINT,PA 19486

来源：

关键词：

D O I：

10.3109/03602539009041088

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：333 / 362

页数：30

共 44 条

[1] DISCOVERY, BIOCHEMISTRY AND BIOLOGY OF LOVASTATIN [J].

ALBERTS, AW .

[2]

ALBERTS AW, 1986, 9TH INT S DRUGS AFF, P8

[3]

Arai M, 1988, SANKYO KENKYUSHO NEM, V40, P1

[4] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].

BROWN, MS ;

GOLDSTEIN, JL .

[5]

CLARK R W, 1989, FASEB Journal, V3, pA953

[6]

DUGGAN D, UNPUB

[7]

DUGGAN DE, 1989, DRUG METAB DISPOS, V17, P166

[8]

DUGGAN DE, 1989, INT ATHEROSCLEROSIS

[9]

EAST C, 1988, NEW ENGL J MED, V318, P47

ENDO, A .

KLINISCHE WOCHENSCHRIFT, 1988, 66 (10) :421-427